On a bustling commercial stretch in East Los Angeles, barbershops, tuxedo rentals and bakeries flank big-name banks and phone ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound ...

The deal could expand access to its in-demand obesity drug at the expense of Eli Lilly, whose shares fell by double digits on ...

CVS Health's revenues increased to $94.6 billion in the first quarter, an increase of 7% compared to the prior year.

(Reuters) -Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists ...

(Reuters) - CVS Health raised its full-year profit forecast on Thursday following strong performance across its businesses, ...

The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per ...

Only days after workers voted overwhelmingly to strike, the Teamsters announced a contract and a snap vote, to the outrage of ...

Jane Birkin was British by blood, but the actress, singer and model was widely considered a French fashion icon. She lived in ...

New reports claim that struggling pharmacy chain Rite Aid is eyeing a second bankruptcy filing. According to the Bloomberg ...